Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Roland SeilerPeter C Black

Abstract

After cisplatin-based neoadjuvant chemotherapy (NAC), 60% of patients with muscle-invasive bladder cancer (MIBC) still have residual invasive disease at radical cystectomy. The NAC-induced biological alterations in these cisplatin-resistant tumors remain largely unstudied. Radical cystectomy samples were available for gene expression analysis from 133 patients with residual invasive disease after cisplatin-based NAC, of whom 116 had matched pre-NAC samples. Unsupervised consensus clustering (CC) was performed and the consensus clusters were investigated for their biological and clinical characteristics. Hematoxylin & Eosin and IHC on tissue microarrays were used to confirm tissue sampling and gene expression analysis. Established molecular subtyping models proved to be inconsistent in their classification of the post-NAC samples. Unsupervised CC revealed four distinct consensus clusters. The CC1-Basal and CC2-Luminal subtypes expressed genes consistent with a basal and a luminal phenotype, respectively, and were similar to the corresponding established pretreatment molecular subtypes. The CC3-Immune subtype had the highest immune activity, including T-cell infiltration and checkpoint molecule expression, but lacked both basal a...Continue Reading

References

Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P SteinD G Skinner
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Jul 2, 2008·BMC Cancer·David LindgrenMattias Höglund
Apr 30, 2010·Bioinformatics·Matthew D Wilkerson, D Neil Hayes
Jan 25, 2011·The Lancet Oncology·Steven Christopher SmithDan Theodorescu
May 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gottfrid SjödahlMattias Höglund
Jan 31, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Feb 13, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey S DamrauerWilliam Y Kim
Aug 7, 2014·Cancer Discovery·Eliezer M Van AllenJonathan E Rosenberg
Sep 27, 2014·European Urology·Homayoun ZargarPeter C Black
Dec 4, 2014·Nature·Antonina V KurtovaKeith Syson Chan
Jan 9, 2015·Cancer Immunology Research·Harold F Dvorak
Oct 31, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sherene LoiJustin M Balko
Nov 13, 2015·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Li-Wu QianKai P Leung
Dec 18, 2015·Journal for Immunotherapy of Cancer·Alessandra Cesano
Jul 2, 2016·Cell·M Angela NietoJean Paul Thiery
Jul 5, 2016·European Urology·J Alfred WitjesMaria J Ribal
Oct 5, 2016·JCI Insight·Jordan KardosBenjamin G Vincent
Dec 3, 2016·Nucleic Acids Research·Minoru KanehisaKanae Morishima
Apr 19, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BellmuntUNKNOWN SOGUG and DUOS
Sep 17, 2017·Scientific Reports·Mathilde Borg Houlberg ThomsenLars Dyrskjøt
Oct 11, 2017·Cell·A Gordon RobertsonSeth P Lerner

❮ Previous
Next ❯

Citations

Nov 11, 2019·Der Pathologe·H Reis, T Szarvas
Jan 30, 2020·Cells·Giulio Eugenio MandelliWilliam Vermi
Jan 27, 2019·World Journal of Urology·Jeffrey J LeowArnulf Stenzl
Sep 3, 2020·International Journal of Molecular Sciences·Juan Carlos PardoAlbert Font
Mar 3, 2020·Frontiers in Oncology·Shaoming ZhuFan Cheng
Jul 4, 2020·Scientific Reports·K E van der VosM S van der Heijden
Aug 14, 2020·International Journal of Molecular Sciences·Martina MinoliRoland Seiler
Aug 28, 2020·Molecular Cancer Therapeutics·Yoshihisa KawaiMartin E Gleave
Mar 4, 2020·Molecular Cancer Research : MCR·Sharada MokkapatiColin P N Dinney
Jan 12, 2021·Urologic Oncology·Ekaterina LaukhtinaUNKNOWN European Association of Urology—Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group
May 4, 2021·European Urology·Gottfrid SjödahlPontus Eriksson
Mar 11, 2021·Cancer Research·Joseph L SottnikDan Theodorescu
Jun 11, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carissa E ChuJonathan Chou
Nov 17, 2021·European Urology·Gottfrid SjödahlFredrik Liedberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.